HOME >> BIOLOGY >> NEWS
Oral Vaccine Protects Infants From Severe Rotavirus Diarrhea

An oral vaccine against rotavirus -- the most important cause of life-threatening diarrhea in children under age 2 -- reduced severe diarrheal illness by 88 percent in a study of more than 2,000 infants in Venezuela. This is the largest and most successful trial to date of a rotavirus vaccine among children in a developing country.

Worldwide, rotavirus diarrhea affects 130 million infants and children each year, some 18 million of whom have moderate to severe disease, resulting in 873,000 deaths.

The study was conducted by Albert Z. Kapikian, M.D., head of the Epidemiology Section of the Laboratory of Infectious Diseases (LID), part of the National Institute of Allergy and Infectious Diseases (NIAID); Irene Perez-Schael, M.D., chief of the Laboratory of Enteric Disease at the Instituto de Biomedicina, Universidad Central de Venezuela in Caracas; and their co-workers. Results are reported Oct. 23 in The New England Journal of Medicine.

"This is the first study designed to determine if the vaccine prevents severe illness in a developing country where rotavirus circulates year-round rather than seasonally," explains Anthony S. Fauci, M.D., NIAID director. "In this setting, the vaccine proved to be very efficacious."

Although rotavirus infection is nearly universal, "The outcome and consequences of rotavirus illness in developed countries are very different from those in developing countries," Dr. Perez-Schael says. Children in developing countries more often develop severe and fatal illness.

Symptoms develop quickly and, in addition to diarrhea, include vomiting, fever and dehydration. In severe cases, a child can experience 10 to 20 episodes of diarrhea and 10 to 15 vomiting episodes per day. Dehydration can be reversed through oral rehydration therapy or, if more serious, through hospitalization and intravenous fluids. Although effective, these therapies are not readily a
'"/>

Contact: Laurie K. Doepel
ldoepel@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
22-Oct-1997


Page: 1 2 3 4 5 6

Related biology news :

1. Hope Clinic of Emory Vaccine Center receives CDC contract
2. Vaccines against foodborne disease on horizon
3. GenVec, U.S. NMRC, and PATHs Malaria Vaccine Initiative partner to expand malaria vaccine efforts
4. Vaccine technique shows potential against common form of lung cancer
5. Fighting fire with fire? Vaccine based on chimp virus shows promise against HIV
6. Emory Vaccine Research Center study identifies specific gene required for long-term immunity
7. Vaccine prevents stroke in rats
8. Vaccine puts blood-sucking ticks off their food
9. Vaccine protects against fatal West Nile complication
10. Dr. Robert C. Gallo to Collaborate with Visiting Israeli Scientist on Promising HIV Vaccine Research at Marylands Institute of Human Virology
11. Vaccine controls AIDS in monkeys, researchers report in Science

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... ... September 12, 2018 , ... JoVE, ... is pleased to support the professional development of academic librarians by sponsoring four ... The entrants were asked to submit successful strategies to increase collaboration among librarians ...
(Date:9/1/2018)... ... 31, 2018 , ... Right this minute, Frenchman Ben Lecomte is hard at work on his ... he’s taken on a new challenge: going from Tokyo to San Francisco, churning his limbs ... on the support boat. As the first expedition of its kind, The Swim is far ...
(Date:8/31/2018)... ... August 30, 2018 , ... USDM Life Sciences , ... sciences and healthcare industries, has received the 2018 Services Partner of the Year, Awarded ... by Box SVP of Business Development and Platform Sales, Niall Wall and received by ...
Breaking Biology News(10 mins):
(Date:8/17/2018)... ... August 16, 2018 , ... The opening of the ... acquired Chemko Technical Services in 2016. Chemko had a well established local presence, servicing ... at KSC on projects such as the ongoing work at the Mobile Launch Platform ...
(Date:8/17/2018)... , ... August 16, 2018 , ... ... announced their results from the AmbryShare project were published today in JAMA Oncology, ... the largest exome study ever conducted. , Every year hereditary breast cancer affects ...
(Date:8/14/2018)... ... ... Labconco Corporation manufactures laboratory equipment, specializing in ventilation enclosures ... other lab equipment, such as glassware washers and freeze dryers. Labconco has ISO ... and manufacturing. , Through this webinar, which is sponsored by Labconco ...
(Date:8/14/2018)... ... August 14, 2018 , ... The growing interest ... of the Chinese Association of Orthopaedic Surgeons (CAOS) held in partnership with the ... Development , Beijing, and Invibio Biomaterial Solutions partnered to demonstrate the ...
Breaking Biology Technology:
Cached News: